Suppr超能文献

意大利成年人群接种疫苗或自然感染麻疹病毒后的血清阳性率

Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy.

作者信息

Anichini Gabriele, Gandolfo Claudia, Fabrizi Simonetta, Miceli Giovan Battista, Terrosi Chiara, Gori Savellini Gianni, Prathyumnan Shibily, Orsi Daniela, Battista Giuseppe, Cusi Maria Grazia

机构信息

Department of Medical Biotechnologies, University of Siena, Santa Maria delle Scotte Hospital, V.le Bracci, 1 53100 Siena, Italy.

Preventive Medicine and Health Surveillance Unit, Santa Maria delle Scotte Hospital, V.le Bracci, 1 53100 Siena, Italy.

出版信息

Vaccines (Basel). 2020 Feb 3;8(1):66. doi: 10.3390/vaccines8010066.

Abstract

An increase in measles cases worldwide, with outbreaks, has been registered in the last few years, despite the availability of a safe and highly efficacious vaccine. In addition to an inadequate vaccination coverage, even in high-income European countries studies proved that some vaccinated people were also found seronegative years after vaccination, thus increasing the number of people susceptible to measles infection. In this study, we evaluated the immunization status and the seroprevalence of measles antibodies among 1092 healthy adults, either vaccinated or naturally infected, in order to investigate the persistence of anti-measles IgG. Among subjects who received two doses of measles vaccine, the neutralizing antibody titer tended to decline over time. In addition, data collected from a neutralization assay performed on 110 healthy vaccinated subjects suggested an inverse correlation between neutralizing antibody titers and the time elapsed between the two vaccinations, with a significant decline in the neutralizing titer when the interval between the two doses was ≥11 years. On the basis of these results, monitoring the serological status of the population 10-12 years after vaccination could be important both to limit the number of people who are potentially susceptible to measles, despite the high efficacy of MMR vaccine, and to recommend a booster vaccine for the seronegatives.

摘要

尽管有安全且高效的疫苗,但在过去几年中,全球范围内已记录到麻疹病例增加并有疫情爆发。除了疫苗接种覆盖率不足外,即使在高收入欧洲国家,研究也证明,一些接种疫苗的人在接种多年后血清学检测仍呈阴性,从而增加了易感染麻疹的人数。在本研究中,我们评估了1092名健康成年人(无论接种疫苗还是自然感染)的免疫状态和麻疹抗体血清流行率,以调查抗麻疹IgG的持久性。在接受两剂麻疹疫苗的受试者中,中和抗体滴度往往随时间下降。此外,对110名健康接种疫苗受试者进行的中和试验收集的数据表明,中和抗体滴度与两次接种之间的时间间隔呈负相关,当两剂之间的间隔≥11年时,中和滴度显著下降。基于这些结果,在接种疫苗10 - 12年后监测人群的血清学状态可能很重要,这既能限制尽管麻疹、腮腺炎、风疹联合疫苗(MMR)疫苗效力高但仍可能易感染麻疹的人数,又能为血清学阴性者推荐加强疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f79b/7158681/b77066a7589e/vaccines-08-00066-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验